New insights into the pathomechanism of cyclic neutropenia

Ann N Y Acad Sci. 2020 Apr;1466(1):83-92. doi: 10.1111/nyas.14309. Epub 2020 Feb 21.

Abstract

Cyclic neutropenia (CyN) is a hematologic disorder in which peripheral blood absolute neutrophil counts (ANCs) show cycles of approximately 21-day intervals. The majority of CyN patients harbor ELANE mutations, but the mechanism of ANC cycling is unclear. We performed analysis of bone marrow (BM) subpopulations in CyN patients at the peak and the nadir of the ANC cycle and detected high proportions of BM hematopoietic stem cells (HSCs) and hematopoietic stem and progenitor cells (HSPCs) at the nadir of the ANC cycle, as compared with the peak. BM HSPCs produced fewer granulocyte colony-forming unit colonies at the ANC peak. To investigate the mechanism of cycling, we found that mRNA expression levels of ELANE and unfolded protein response (UPR)-related genes (ATF6, BiP (HSPA5), CHOP (DDIT3), and PERK (EIF2AK3)) were elevated, but antiapoptotic genes (Bcl-2 (BCL2) and bcl-xL (BCL2L1)) were reduced in CD34+ cells tested at the ANC nadir. Moreover, HSPCs revealed increased levels of reactive oxygen species and gH2AX at the ANC nadir. We suggest that in CyN patients, some HSPCs escape the UPR-induced endoplasmic reticulum (ER) stress and proliferate in response to granulocyte colony-stimulating factor (G-CSF) to a certain threshold at which UPR again affects the majority of HSPCs. There is a cyclic balance between ER stress-induced apoptosis of HSPCs and compensatory G-CSF-stimulated HSPC proliferation followed by granulocytic differentiation.

Keywords: DNA damage; ELANE mutations; ROS; UPR; cyclic neutropenia (CyN).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow / drug effects
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Cells, Cultured
  • Endoplasmic Reticulum Chaperone BiP
  • Endoplasmic Reticulum Stress / drug effects
  • Endoplasmic Reticulum Stress / genetics
  • Endoplasmic Reticulum Stress / physiology*
  • Follow-Up Studies
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoiesis / drug effects
  • Hematopoiesis / genetics
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / pathology
  • Hematopoietic Stem Cells / physiology
  • Humans
  • Leukocyte Elastase / genetics*
  • Leukocyte Elastase / physiology
  • Mutation
  • Neutropenia / drug therapy
  • Neutropenia / etiology*
  • Neutropenia / metabolism
  • Neutropenia / pathology
  • Reactive Oxygen Species / metabolism
  • Severity of Illness Index
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Unfolded Protein Response / drug effects
  • Unfolded Protein Response / genetics
  • Unfolded Protein Response / physiology*

Substances

  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Reactive Oxygen Species
  • Granulocyte Colony-Stimulating Factor
  • ELANE protein, human
  • Leukocyte Elastase

Supplementary concepts

  • Cyclic neutropenia